| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |